Out-Licensing

← All Categories

• Korean Biotech at BIO USA 2026: Licensing Deals Over Product Launches July 19, 2026

  Korean drugmakers used BIO USA 2026 to court partners rather than launch products, with Curacle's 1.6 trillion won deal setting the benchmark.